Dr. Khan on the Rationale of Examining Disparate Outcomes in GI Tract Cancer Surgery

Video

In Partnership With:

Sajid A. Khan MD, FACS, FSSO, discusses the rationale of examining disparate outcomes in gastrointestinal tract cancer surgery.

Sajid A. Khan MD, FACS, FSSO, associate professor of surgery (oncology), Yale School of Medicine, section chief, Hepato-Pancreato-Biliary and Mixed Tumors, co-director, Team Science, Yale Center for Clinical Investigation, Yale Cancer Center, discusses the rationale of examining disparate outcomes in gastrointestinal (GI) tract cancer surgery.

The COVID-19 pandemic brought forth preexisting racial and ethnic disparities that exist in the treatment of patients, Khan says. Moreover, GI cancer accounts for approximately 35% of cancer-related deaths, with African Americans having a higher GI cancer burden compared with White patients and a higher risk of death due to GI cancer, Khan explains. Because of this, a retrospective cohort study was conducted to examine whether there are disparate outcomes in GI tract cancer surgery based on race and ethnicity, Khan adds.

Although there have been smaller studies focusing on GI surgical oncology, there have not been any studies that have looked comprehensively at all GI cancer surgery outcomes and their relation to treatment disparities, Khan concludes.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD